Matthew Block~~Amanda M. Burke~~Adam M. Turteltaub
January 24, 2026
Willkie Advises Council Ring Capital on Lead Investment in DevCo Capital Raise for Medix Biochemica

1 min
AI-made summary
- Willkie advised Council Ring Capital as the lead investor in DevCo Partners Ltd’s €616 million investment vehicle, aimed at supporting the growth of Medix Biochemica
- On September 3, DevCo announced it raised €616 million from an investor group led by Council Ring Capital for a long-term single asset investment in Medix Biochemica, a global supplier of biological raw materials for the in vitro diagnostics industry
- The Willkie team was led by three partners.
Willkie advised Council Ring Capital as lead investor in DevCo Partners Ltd’s €616 million investment vehicle to support the continued growth of Medix Biochemica. On September 3, DevCo announced that it raised €616 million from an investor group led by Council Ring Capital for its long-term single asset investment vehicle for Medix Biochemica, a leading independent supplier of critical biological raw material products to the in vitro diagnostics industry worldwide. Based in Chicago, Council Ring Capital is a single-family office investing in growing businesses across the healthcare, technology, and consumer sectors. The Willkie team was led by partners Matthew Block, Amanda M. Burke and Adam Turteltaub.
Article Author
Matthew Block~~Amanda M. Burke~~Adam M. Turteltaub
The Sponsor
